Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Next-generation vaccine platforms for COVID-19

Nature Materials(2020)10.1038/s41563-020-0746-0Source: DataRank Database

Next-generation vaccine platforms for COVID-19 is a research paper published in Nature Materials (2020). On theSindex it has a DataRank of 0.893. It has been cited 385 times.

N/A

0.893DataRank · unranked

Scored on demand from live citation data

Open Access385 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 7.79)OA: bronzeTopics (29)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.893

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

Emmie de Wit ORCID,Debby van Riel ORCID

Live enrichment

PubMed:32704139 OpenAlex:https://openalex.org/W3044336785

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Grant: 91718308

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

FWCI

7.79

Citation Percentile

1.0%

Citation Trend

2018

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: https://www.springer.com/tdm

journalhttps://www.nature.com/articles/s41563-020-0746-0.pdf

publisherhttps://www.nature.com/articles/s41563-020-0746-0.pdf

publisherhttps://www.nature.com/articles/s41563-020-0746-0

journalhttps://doi.org/10.1038/s41563-020-0746-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32704139

Fields of Study

Viral Infections and Outbreaks ResearchSARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesBetacoronavirusCOVID-19COVID-19 VaccinesCoronavirus InfectionsHumansPandemicsPneumonia, ViralSARS-CoV-2Viral Vaccines

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2COVID-19 VaccinesHumansPneumonia, ViralViral VaccinesCoronavirus InfectionsPandemics

Keywords

Coronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyComputer scienceMedicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of Fundamental challenges in assessing the impact of research infrastructure

10.6084/m9.figshare.15253707.v1figshare

Additional file 2 of Fundamental challenges in assessing the impact of research infrastructure

10.6084/m9.figshare.15253707figshare

Additional file 1 of Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

10.6084/m9.figshare.14702443.v1figshare

Additional file 1 of Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

10.6084/m9.figshare.14702443figshare

Additional file 2 of Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

10.6084/m9.figshare.14702446.v1figshare